Eansor N David
President-Protein Sciences at TECH; Other at CAMBREX CORP
- Sold, on record
- $37.4M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Nov 12, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- TECHBIO-TECHNE CorpPresident-Protein Sciences
- CAMBREX CORPOther
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- TECH102,264 shares
- CAMBREX CORP1,439 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TECHUnusualMay 4, 2018 2018
Sold 1,136 shares at $145.19 ($165k)
Eansor Norman David, SVP - Novus Biologicals
Sold 33.4% of holdings ($494k position)2,266 shares leftFirst sale on recordFiling
- 2 Form 4 sale TECHUnusualJun 12, 2019 +404 days
Sold 3,117 shares at $215.00 ($670k)
Eansor Norman David, SVP - Novus Biologicals
Sold 100% of holdings ($670k position)0 shares leftFiling
- 3 Form 4 sale TECHUnusualMar 4, 2020 +266 days
Sold 1,387 shares at $198.68 ($276k)
Eansor Norman David, President-Protein Sciences
Sold 100% of holdings ($276k position)0 shares leftFiling
- 4 Form 4 sale TECHUnusualMay 22, 2020 +79 days
Sold 23,637 shares at $267.73 ($6.3M)
Eansor Norman David, President-Protein Sciences
Sold 100% of holdings ($6.3M position)0 shares leftFiling
- 5 Form 4 sale TECHUnusualMay 29, 2020 +7 days
Sold 11,357 shares at $261.45 ($3M)
Eansor Norman David, President-Protein Sciences
Sold 100% of holdings ($3M position)0 shares left3.6x usual sizeFiling
- 6 Form 4 sale TECHUnusualFeb 5, 2021 +252 days
Sold 32,933 shares at $380.68 ($12.5M)
Eansor Norman David, President-Protein Sciences
Sold 96.2% of holdings ($13M position)1,318 shares left4.6x usual sizeFiling
- 7 Form 4 sale TECHUnusualAug 31, 2021 +207 days
Sold 1,538 shares at $503.07 ($774k)
Eansor Norman David, President-Protein Sciences
Sold 53.9% of holdings ($1.4M position)1,318 shares left0.1x usual sizeFiling
- 8 Form 4 sale TECHUnusualNov 12, 2021 +73 days
Sold 27,159 shares at $504.00 ($13.7M)
Eansor Norman David, President-Protein Sciences
Sold 95.4% of holdings ($14.4M position)1,318 shares left2.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | Nov 16, 2021 | TECH | President-Protein Sciences | Form 4 sale | 27,159 | $13.7M | 95.4% | Unusual | SEC |
| Aug 31, 2021 | Sep 2, 2021 | TECH | President-Protein Sciences | Form 4 sale | 1,538 | $774k | 53.9% | Unusual | SEC |
| Feb 5, 2021 | Feb 9, 2021 | TECH | President-Protein Sciences | Form 4 sale | 32,933 | $12.5M | 96.2% | Unusual | SEC |
| May 29, 2020 | Jun 1, 2020 | TECH | President-Protein Sciences | Form 4 sale | 11,357 | $3M | 100.0% | Unusual | SEC |
| May 22, 2020 | May 26, 2020 | TECH | President-Protein Sciences | Form 4 sale | 23,637 | $6.3M | 100.0% | Unusual | SEC |
| Mar 4, 2020 | Mar 6, 2020 | TECH | President-Protein Sciences | Form 4 sale | 1,387 | $276k | 100.0% | Unusual | SEC |
| Jun 12, 2019 | Jun 14, 2019 | TECH | SVP - Novus Biologicals | Form 4 sale | 3,117 | $670k | 100.0% | Unusual | SEC |
| May 4, 2018 | May 11, 2018 | TECH | SVP - Novus Biologicals | Form 4 sale | 1,136 | $165k | 33.4% | Unusual | SEC |
| Jan 6, 2006 | Jan 6, 2006 | CAMBREX CORP | Other | Form 4 sale | 1,439 | $29k | 18.6% | Plan not stated | SEC |